---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-26-000084"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2026-05-29T21:07:05+00:00"
generated_at: "2026-05-29T21:08:18.689296+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BRTX shareholders approve 20x increase in authorized shares; CEO/CFO sign 3-year employment agreements

## Summary
- CEO Lance Alstodt signed 3-year employment agreement with $600k annual salary, unchanged.
- CFO Robert Kristal signed 3-year employment agreement with $350k annual salary, unchanged.
- Shareholders approved increase in authorized common shares from 75M to 1.5B (20x).
- Vote: 9,868,606 for, 2,389,059 against, 179,207 abstentions.

## SEC filing metadata
- accession: 0001021771-26-000084
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2026-05-29T21:07:05+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000084/0001021771-26-000084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000084/brtx-20260529.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-26-000084
- JSON: https://secwatch.observer/filing/0001021771-26-000084.json
- Plain text: https://secwatch.observer/filing/0001021771-26-000084.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.